Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction

Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction

US Patent 9556180 · Granted Jan 31, 2017

Estimated economic value: $9,161,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of 2025
Hemagglutinin-binding peptide2025
Method for producing peptide compound2025
Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Bicyclic compounds and their uses2024
Pyrazolyl derivatives useful as anti-cancer agents2023
Pyrazolyl derivatives useful as anti-cancer agents2023
Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitors2023
3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide2023